An Act relative to limiting the potency of THC products
Bill H 191 caps THC potency in Massachusetts cannabis products to address public health concerns around addiction and mental health effects.
Bill H 191 caps THC potency in Massachusetts cannabis products to address public health concerns around addiction and mental health effects.
H 191 proposes to establish limits on the potency of tetrahydrocannabinol (THC) in cannabis products sold in Massachusetts. The bill would cap the maximum allowable THC concentration in various cannabis products, likely including flower, concentrates, and edibles. This represents a regulatory constraint on the legal cannabis market that Massachusetts has permitted since 2016.
THC potency in cannabis products has increased significantly over the past decade, with some concentrates exceeding 90% THC. Potency limits directly affect consumer access, product pricing, tax revenue, and public health outcomes—particularly regarding cannabis use disorder, impaired driving risks, and mental health effects in vulnerable populations. The bill could reshape Massachusetts' competitive cannabis market and its estimated $2+ billion annual industry.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.